Ligand-induced conformational change in the minimized insulin receptor

Journal of Molecular Biology

Volumn 303, Issue 2, 2000, Pages 161-169

  Schlein, Morten ^a   Havelund, Svend ^a   Kristensen, Claus ^a   Dunn, Michael F ^b   Kaarsholm, Niels C ^a  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fluorescently labeled insulin; Hormone receptor dynamics; Insulin receptor; Stopped flow kinetics

Indexed keywords

INSULIN RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CROSS LINKING; CRYSTAL STRUCTURE; INSULIN BINDING; LIGAND BINDING; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; X RAY CRYSTALLOGRAPHY;

ANIMALIA;

EID: 0034692924     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.4134     Document Type: Article

References (42)

1. Changing the insulin receptor to possess insulin-like growth factor I ligand specificity
2. The structure of 2Zn pig insulin crystals at 1.5 Å resolution
3. Fluorescent-labeled growth factor molecules serve as probes for receptor binding and endocytosis
4. Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor
5. Crystal structure of the activated insulin receptor tvrosine kinase in complex with peptide substrate and ATP analog
6. Crystal structure of the tyrosine kinase domain of the human insulin receptor
7. Characterization of ligand binding of a soluble human insulin-like growth factor I receptor variant suggests a ligand-induced conformational change
8. Interaction between the A2 and A19 amino acid residues is of critical importance for high biological activity in insulin: (19-Leucine-A)insulin
9. Expression and characterization of a 70-kDa fragment of the insulin receptor that binds insulin. Minimizing ligand binding domain of the insulin receptor
10. Specificity of insulin and insulin-like growth factor I receptors investigated using chimeric mini-receptors: Role of C-terminal of receptor alpha subunit
11. Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor
12. Spectroscopic and immunochemical studies with nitrobenzoxadiazolealanine, a fluorescent dinitrophenyl analogue
13. Conformational changes of the insulin receptor upon insulin binding and activation as monitored by fluorescence spectroscopy
14. High-resolution structure of an engineered biologically potent insulin monomer, B16 Tyr → His, as determined by nuclear magnetic resonance spectroscopy
15. A structural switch in a mutant insulin exposes key residues for receptor binding
16. Quaternary structure of the insulin-insulin receptor complex
17. The insulin receptor: From protein sequence to structure
18. Synthesis and biological activity of seventeen analogues of human insulin
19. Immobilized insulin for high capacity affinity chromatography of insulin receptors
20. The first structure of a receptor tyrosine kinase domain: A further step in understanding the molecular basis of insulin action
21. Role of the phenylalanine B24 side-chain in directing insulin interaction with its receptor. Importance of main chain conformation
22. A simple free fat cell bioassay for insulin
23. A third fibronectin-type-III domain in the insulin-family receptors letter
24. Alanine-scanning mutagenesis of a C-terminal ligand binding domain of the insulin receptor alpha subunit
25. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions
26. Axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase
27. Solution structure of an engineered insulin monomer at neutral pH
28. The relationship between insulin bioactivity and structure in the NH2- terminal A-chain helix
29. Properties of spin and fluorescent labels at a receptor-ligand interface
30. How to measure and predict the molar absorption coefficient of a protein
31. The interaction of epidermal growth factor with its receptor in A431 cell membranes: A stopped-flow fluorescence anisotropy study
32. Structural organization of the human insulin receptor ectodomain
33. 12-asparagine-B human insulin. An analogue with modification in the hydrophobic core of insulin
34. The disulfide bonds in the C-terminal domains of the human insulin receptor ectodomain
35. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
36. Members of the insulin receptor family contain three fibronectin type III domains
37. Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor
38. Hormone binding site of the insulin receptor: Analysis using photoaffinity-mediated avidin complexing
39. The insulin signaling system
40. Mapping of an NH2-terminal ligand-binding site of the insulin receptor by alanine scanning mutagenesis
41. Structural studies of the detergent-solubilized and vesicle-reconstituted insulin receptor